News
Projects
Orgs
Project
Articles 71
Votes 0
FiercePharma

Authors 7

FiercePharma
Zoey Becker
Kevin Dunleavy
Max Bayer
Angus Liu
Nick Paul Taylor
Fraiser Kansteiner
SCOTUS hands win to Sanofi, Regeneron in long-running PCSK9 feud with Amgen - FiercePharma
almost3y
Takeda braces for impact as Vyvanse edges toward the patent cliff - FiercePharma
almost3y
In $1.7B buy, Sobi acquires CTI and myelofibrosis drug Vonjo - FiercePharma
almost3y
After production problems, Catalent delays earnings and plans to slash guidance - FiercePharma
almost3y
Merck defeats insurers in $1.4B cyberattack appeal - FiercePharma
almost3y
Pfizer, Astellas detail Xtandi win in earlier prostate cancer - FiercePharma
almost3y
With negative FDA panel vote, AstraZeneca may look at narrow Lynparza nod in prostate cancer - FiercePharma
almost3y
With big launches on tap, Sanofi CEO Paul Hudson touts company's 'new steady state' - FiercePharma
almost3y
Aduhelm continues to haunt Biogen, causing $18M Alzheimer's hit - FiercePharma
almost3y
Apellis hits setback in ALS trial after pair of pegcetacoplan approvals - FiercePharma
almost3y
Embracing Personalization in Biopharma Patient Support Programs - FiercePharma
almost3y
Roche wins hard-fought approval for Polivy in earlier lymphoma - FiercePharma
almost3y
Struggling Gamida wins long-awaited FDA approval for Omisirge - FiercePharma
almost3y
AACR: AstraZeneca's Imfinzi lung cancer data raise new questions - FiercePharma
almost3y
FDA advisers back Lundbeck and Otsuka's Rexulti in Alzheimer's disease agitation - FiercePharma
almost3y
GlobalData warns of added COVID vaccine market uncertainty - FiercePharma
almost3y
FDA pulls the plug on Covis' troubled preterm birth med Makena - FiercePharma
almost3y
COPD nod could be worth $3.5B for Sanofi, Regeneron's Dupixent - FiercePharma
~3y
Astellas, Pfizer look to broaden Xtandi's patient base with new prostate cancer win after 8 years - FiercePharma
~3y
Novo Nordisk to launch weight drug Wegovy in UK - FiercePharma
~3y
FDA gives Eisai's Leqembi a July 6 priority review date - FiercePharma
~3y